Grant·JNCRaUbBif·Record

Grant JNCRaUbBif

Verdictconfirmed95%

1 check · 4/29/2026

1 → confirmed

Our claim

entire record

Name: Charak Foundation — Ramatroban Clinical Trial
Amount: $1,015,686
Currency: USD
Date: March 2022
Source: https://coefficientgiving.org/funds/
Notes: [Human Health and Wellbeing] Open Philanthropy recommended a grant of $1,015,686.03 to the Charak Foundation to fund the initial stages of a clinical trial of ramatroban for the suppression of life-threatening symptoms of COVID-19 infections. Ramatroban is a pill approved for sa… expand
[Human Health and Wellbeing] Open Philanthropy recommended a grant of $1,015,686.03 to the Charak Foundation to fund the initial stages of a clinical trial of ramatroban for the suppression of life-threatening symptoms of COVID-19 infections. Ramatroban is a pill approved for sale and use against allergic rhinitis in Japan, and has been used for over twenty years without incident. The trial will involve the recruitment of people who have been admitted to hospitals with COVID-19. The treatment cohort will be followed for 4-6 months to assess outcomes that include mortality, hypoxemia, length of hospital stay, cytopenia, pulmonary fibrosis, and symptoms related to “long COVID.” This falls within our focus area of scientific research, and specifically within our interest in advancing human health and wellbeing. The grant amount was updated in May 2025.

1 src · 1 check

confirmed95%deterministic-row-match · 4/20/2026

NoteDeterministic match: grantee, amount, date matched in source snapshot (2714 rows)

Case № JNCRaUbBifFiled 4/29/2026Confidence 95%